Dear All, A key theme of all discussions on Pull incentives is that substantial rewards should go only to molecules with high medical value. We’re still learning to define the idea of high value and today’s newsletter brings together 3 threads that feed into this conversation: First, we have the idea a priority pathogen list.
Dear All (and with thanks to Kevin for co-authoring), For today, a wonkish potpourri of data to support action. As you’ll see, this string of pearls is deeply connected: A UN Environment Programme (UNEP) report, An analysis of the global response to AMR during 2020-21 in 114 countries, A summary of the path to (and next steps for) the UK’s
Dear All, Today we have several useful papers to share. First, OHE (Office of Health Economics, London) have posted a 4-part blog series that provides a succinct summary of the broken economics of antibiotics. The titles are good guides to content: Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment
Dear All, Three things today… First, there is a newly announced hearing by the House Energy and Commerce at 9AM on this Friday, 28 April entitled “Antimicrobial Resistance: Examining an Emerging Public Health Threat.” Go here for details including a link for a livestream of hearing. It’s exciting to see this coming up … hopefully, it
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), Exciting and intriguing news to share about PASTEUR (and see this 16 June 2021 newsletter if you need a refresher on the ideas behind PASTEUR)! A new draft is now circulating with the intent of attaching it to a larger bill that is on track
Dear All (wonkish alert … get your coffee!), EFPIA have recently released a report estimating the value of a Transferable Exclusivity Extension (TEE, report, press release) that provides new generalized insights into ways to think about the value of new antibiotics and the appropriate size of the Pull rewards needed to bring that new antibiotic
Dear All, The US Government is now building its budget for FY23 (Federal Year 2023, really runs 1 Oct 22 to 30 Sep 23). We had proposals from the House for the Department of Health and Human Services (DHHS) budget in late June; and the proposal from Senate was released on 28 Jul 2022. Each
Dear All, The G7 Health Ministers met 19-20 May 2022 in Berlin. As you might expect, their communique covered a range of topics but focused on four priority areas: (1) Overcoming COVID-19, (2) Future pandemic preparedness, (3) AMR, and (4) Health risks from climate change. You should review the entire communique; I will excerpt from
Dear All, Two stops on our tour today: (i) an excellent survey of incentive models and (ii) a final communique from the recent G7 meetings. First up, CGD (Center for Global Development) have released a report (link) entitled “Leveraging Purchasing Systems to Ensure Access, Stewardship, and Innovation: A Landscape Review of Current and Potential Market Structures
Dear All, On the heels of yesterday’s (i) patient-focused meeting at the Capitol yesterday where 5 Members of Congress spoke in person (video, press release) in support of passage of the PASTEUR Act and (ii) strong shout-out to PASTEUR by Congressman Mike Doyle during the Energy and Commerce Committee markup session, CARB-X today announced commitments of